2021
|
Invention
|
Intermediate of pregabalin and preparation method therefor. Disclosed are an intermediate of preg... |
|
Invention
|
Pyridinyl morpholine compound, preparation method therefor, and application thereof.
Disclosed i... |
|
Invention
|
Pyridinyl morpholine compound, preparation method therefor, and application thereof. 232A2A, and ... |
|
Invention
|
Benzonitric heterocyclic compound, preparation method therefor and use thereof.
Disclosed are a ... |
|
Invention
|
Benzonitric heterocyclic compound, preparation method therefor and use thereof. Disclosed are a b... |
2020
|
Invention
|
Biological peptide for treating lung diseases and application thereof. Provided is a biological p... |
|
Invention
|
Method for preparing saccharin compound. Disclosed is a method for preparing a saccharin compound... |
|
Invention
|
Phenyl containing compound, intermediate thereof, preparation method therefor and application the... |
|
Invention
|
Phenyl-containing compound, intermediate thereof, preparation method therefor and application the... |
2019
|
Invention
|
Amphotericin b peptide derivative. The present disclosure relates to the field of medicine, and s... |
|
Invention
|
Hydrate of 4-(1-hydroxy-1-methylethyl)-2-propylimidazole-5-carboxylic acid ethyl ester. The prese... |
|
Invention
|
Use of chlorophyll dihydroporphin as plant growth regulator. Disclosed is the use of chlorophyll ... |
2018
|
Invention
|
Polymyxin analogue and preparation method therefor. The present invention belongs to the field of... |
|
Invention
|
Application of ginsenoside ck in preparation of oral medication for treating moderate-severe psor... |
|
Invention
|
Novel rhodamine dye and application thereof against pathogenic bacteria. The present invention re... |
|
Invention
|
Intermediate compounds for preparation of praziquantel and processes for preparing the intermedia... |
|
Invention
|
Microbial agent for prevention of intestinal toxicity due to tumor chemotherapy. A microbial agen... |
2017
|
Invention
|
Process for preparation of novel androgen receptor antagonist. A process for the preparation of a... |
|
Invention
|
High-titer polymyxin e2 sodium methanesulfonate. Provided are a high-titer polymyxin E2 sodium me... |
|
Invention
|
Method for biologically preparing (1r,2s)-2-(3,4-difluorophenyl)cyclopropanamine d-mandelate (i).... |
|
Invention
|
Salt derivative of tetrahydroisoquinoline and crystalline thereof and preparation method therefor... |
|
Invention
|
Method for preparing trabectedin and intermediates thereof. Provided in the present invention is ... |
|
Invention
|
Process for preparing dapagliflozin eutectic matter. Provided is a process for preparing a dapagl... |
2016
|
Invention
|
Separation and purification method for epirubicin or hydrochloride thereof. Provided are a separa... |
|
Invention
|
Ipragliflozin preparation method. Provided in the present invention is an ipragliflozin synthesis... |
|
Invention
|
Method and intermediate for the preparation of epirubicin hydrochloride. The present invention di... |
2015
|
Invention
|
Method for separating diastereoisomer a of bedaquiline. Disclosed is a method for separating a di... |
|
Invention
|
Podophyllotoxin derivative, and preparation method, pharmaceutical composition and use thereof. D... |
|
Invention
|
Preparation method for praziquantel and intermediate compounds thereof. Disclosed is a preparatio... |
|
Invention
|
Preparation method for praziquantel and intermediate compounds thereof. Disclosed are a preparati... |
2014
|
Invention
|
Mirabegron-related substance or salt thereof, and preparation method and use thereof. Disclosed i... |
|
Invention
|
Endo-(14s)-3-methoxy-17-methylmorphinan picrate and preparation method and use thereof. During th... |
|
Invention
|
Podophyliotoxin derivative, and preparation method, pharmaceutical composition and use thereof. D... |
|
Invention
|
Method for preparing a sitagliptin intermediate. The present invention provides a method for prep... |
|
Invention
|
Method for preparing intermediate compound of sitagliptin. The present invention provides a metho... |
|
Invention
|
Forms of co-crystals of agomelatine and p toluenesulphonic acid, a process for their preparation ... |
|
Invention
|
Novel forms of co-crystals of agomelatine and p-toluenesulphonic acid, method for preparing same ... |
|
Invention
|
Complexes of agomelatine and sulphonic acids, a process for their preparation and pharmaceutical ... |
|
Invention
|
Novel complexes of agomelatine and sulphonic acids, method for preparing same and the pharmaceuti... |
|
Invention
|
Method for preparing dabigatran etexilate intermediate, and intermediate compound. 3 alkyl alcoho... |
|
Invention
|
Method of preparing dabigatran etexilate intermediate and intermediate compound. Disclosed are a ... |
|
Invention
|
4-benzyl-1-phenethyl-piperazine-2,6-dione preparation method, and intermediate and preparation me... |
|
Invention
|
Platinum (ii) compound, preparation method therefor, and pharmaceutical composition and applicati... |
2013
|
Invention
|
Glycopeptide compound or pharmaceutical salt thereof and method for preparing same, and pharmaceu... |
|
Invention
|
Stabilised amorphous form of agomelatine, a process for its preparation and pharmaceutical compos... |
|
Invention
|
New agomelatine p-toluenesulfonic acid co-crystal forms and preparation thereof. The present inve... |
|
Invention
|
Agomelatine sulfonic acids complexes and preparation thereof. Disclosed are agomelatine sulfonic ... |
|
Invention
|
3-cyanoanilinoalkylarylpiperazine derivative and use thereof in preparing drugs. Disclosed in the... |
|
Invention
|
Method for preparing rivaroxaban intermediate. A method for preparing a Rivaroxaban intermediate ... |